XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock (Class A and B)
Additional Paid-in-Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Shares, Outstanding, Beginning at Dec. 31, 2019   46,639,000      
Beginning of the period at Dec. 31, 2019 $ 54,202 $ 47 $ 420,170 $ 287 $ (366,302)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 9,936   9,936    
Issuance of common stock upon exercise of stock options (in shares)   225,000      
Issuance of common stock upon exercise of stock options 2,794 2,794    
Issuance of common stock under employee stock purchase plan (in shares)   94,000      
Issuance of common stock under employee stock purchase plan 3,660   3,660    
Issuance of restricted stock units (in shares)   117,000      
Tax withholding related to net share settlements of stock-based compensation awards (in shares)   (30,000)      
Tax withholding related to net share settlements of stock-based compensation awards (1,379)   (1,379)    
Net loss (10,418)       (10,418)
Other comprehensive income (loss) (9)     (9)  
Shares, Outstanding, Ending at Mar. 31, 2020   47,045,000      
End of period at Mar. 31, 2020 58,786 $ 47 435,181 278 (376,720)
Shares, Outstanding, Beginning at Dec. 31, 2019   46,639,000      
Beginning of the period at Dec. 31, 2019 54,202 $ 47 420,170 287 (366,302)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (30,030)        
Other comprehensive income (loss) 381        
Shares, Outstanding, Ending at Jun. 30, 2020   47,620,000      
End of period at Jun. 30, 2020 60,390 $ 47 456,007 668 (396,332)
Shares, Outstanding, Beginning at Mar. 31, 2020   47,045,000      
Beginning of the period at Mar. 31, 2020 58,786 $ 47 435,181 278 (376,720)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 14,894   14,894    
Issuance of common stock upon exercise of stock options (in shares)   443,000      
Issuance of common stock upon exercise of stock options 6,664 $ 0 6,664    
Issuance of restricted stock units (in shares)   153,000      
Tax withholding related to net share settlements of stock-based compensation awards (in shares)   (21,000)      
Tax withholding related to net share settlements of stock-based compensation awards (732)   (732)    
Net loss (19,612)       (19,612)
Other comprehensive income (loss) 390     390  
Shares, Outstanding, Ending at Jun. 30, 2020   47,620,000      
End of period at Jun. 30, 2020 60,390 $ 47 456,007 668 (396,332)
Shares, Outstanding, Beginning at Dec. 31, 2020   48,789,000      
Beginning of the period at Dec. 31, 2020 64,277 $ 49 478,698 230 (414,700)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 11,623   11,623    
Issuance of common stock upon exercise of stock options (in shares)   312,000      
Issuance of common stock upon exercise of stock options 4,138 $ 1 4,137    
Issuance of common stock under employee stock purchase plan (in shares)   93,000      
Issuance of common stock under employee stock purchase plan 4,237   4,237    
Issuance of restricted stock units (in shares)   803,000      
Tax withholding related to net share settlements of stock-based compensation awards (in shares)   (70,000)      
Tax withholding related to net share settlements of stock-based compensation awards (7,146)   (7,146)    
Net loss (7,324)       (7,324)
Other comprehensive income (loss) (49)     (49)  
Shares, Outstanding, Ending at Mar. 31, 2021   49,927,000      
End of period at Mar. 31, 2021 69,756 $ 50 491,549 181 (422,024)
Shares, Outstanding, Beginning at Dec. 31, 2020   48,789,000      
Beginning of the period at Dec. 31, 2020 $ 64,277 $ 49 478,698 230 (414,700)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 429,696        
Net loss $ (16,838)        
Other comprehensive income (loss) (26)        
Shares, Outstanding, Ending at Jun. 30, 2021   50,354,000      
End of period at Jun. 30, 2021 72,066 $ 50 503,350 204 (431,538)
Shares, Outstanding, Beginning at Mar. 31, 2021   49,927,000      
Beginning of the period at Mar. 31, 2021 69,756 $ 50 491,549 181 (422,024)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 11,052   11,052    
Issuance of common stock upon exercise of stock options (in shares)   117,000      
Issuance of common stock upon exercise of stock options 1,480 $ 0 1,480    
Issuance of restricted stock units (in shares)   318,000      
Tax withholding related to net share settlements of stock-based compensation awards (in shares)   (8,000)      
Tax withholding related to net share settlements of stock-based compensation awards (731)   (731)    
Net loss (9,514)       (9,514)
Other comprehensive income (loss) 23     23  
Shares, Outstanding, Ending at Jun. 30, 2021   50,354,000      
End of period at Jun. 30, 2021 $ 72,066 $ 50 $ 503,350 $ 204 $ (431,538)